NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM545753 Query DataSets for GSM545753
Status Public on Dec 31, 2011
Title S012_Scz_M_63
Sample type RNA
 
Source name Brain BA22 post-mortem schizophrenic
Organism Homo sapiens
Characteristics gender: Male
age: 63
post-mortem delay: 30h
ph: 6.5
disease state: schizophrenic
tissue: superior temporal cortex (Brodmann Area 22, BA22)
Extracted molecule total RNA
Extraction protocol Total RNA was extracted from frozen BA22 using a Polytron type homogenizer (YellowLine DI 25 Basic) and TriZol reagent (Invitrogen, Paisley, UK) in a ratio of 1 ml of TriZol to 20 mg of tissue. RNA was further purified using RNeasy mini-columns (Qiagen, Valencia, CA, USA) including on-column DNAse-1 step and elution in water. Although pH was analysed in brain lysates using a pH meter, this was not considered to be rigorous enough to exclude or include samples and instead the RNA integrity number (RIN) was used to assess the quality of the RNA as the primary inclusion criterion. The quantity of extracted RNA was determined by spectrophotometry and quality was assessed using an Agilent 2100 Bioanalyzer (South Plainfield, NJ, USA) to determine the RIN. Based on the RIN, samples were classified into three quality groups—pass (RIN >7.0); borderline (RIN 6.0–7.0); fail (RIN<6.0). Following classification, there were 41 pass (RIN range of samples 7.0–9.0: average=7.7), 16 borderline (RIN range of samples 6.0–6.9; average=6.4) and 5 fail samples. Samples in the fail category were excluded from the study, and the remaining samples were randomized into four batches, containing an equal number of schizophrenic/control and male/female samples, for target generation and hybridization.
Label biotin
Label protocol For each batch, 10ug total RNA was processed to Biotin-labeled cRNA and hybridized to HG-U133_Plus_2.0 GeneChips in accordance with the Affymetrix protocol (Affymetrix, Santa Clara, CA, USA,).
 
Hybridization protocol For each batch, 10ug total RNA was processed to Biotin-labeled cRNA and hybridized to HG-U133_Plus_2.0 GeneChips in accordance with the Affymetrix protocol (Affymetrix, Santa Clara, CA, USA,).
Scan protocol Arrays were scanned on a GeneChip Scanner 3000 and fluorescence intensity for each feature of the array was obtained by using GeneChip Operating Software (Affymetrix).
Description n/a
Data processing The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 150.
 
Submission date May 20, 2010
Last update date Dec 31, 2011
Contact name Julie Huxley-Jones
E-mail(s) [email protected]
Phone 01438 768416
Organization name GlaxoSmithKline Pharmaceuticals
Department Computational Biology
Street address Gunnels Wood Road
City Stevenage
State/province Hertfordshire
ZIP/Postal code SG1 2NY
Country United Kingdom
 
Platform ID GPL570
Series (1)
GSE21935 Comparison of post-mortem tissue from Brodman Brain BA22 region between schizophrenic and control patients

Data table header descriptions
ID_REF
VALUE MAS5.0 signal intensity

Data table
ID_REF VALUE
AFFX-BioB-5_at 311.1636047
AFFX-BioB-M_at 398.4786682
AFFX-BioB-3_at 231.5908508
AFFX-BioC-5_at 630.1533203
AFFX-BioC-3_at 613.6044922
AFFX-BioDn-5_at 1065.473145
AFFX-BioDn-3_at 3202.84375
AFFX-CreX-5_at 6954.055176
AFFX-CreX-3_at 8063.663086
AFFX-DapX-5_at 7.262554646
AFFX-DapX-M_at 14.78204632
AFFX-DapX-3_at -1.536681294
AFFX-LysX-5_at 8.023086548
AFFX-LysX-M_at 3.616162062
AFFX-LysX-3_at 3.35831666
AFFX-PheX-5_at 1.349555373
AFFX-PheX-M_at -13.57560253
AFFX-PheX-3_at 4.687495709
AFFX-ThrX-5_at -5.415935516
AFFX-ThrX-M_at 0.510175169

Total number of rows: 54675

Table truncated, full table size 1223 Kbytes.




Supplementary file Size Download File type/resource
GSM545753_jrs_U133p2_DB2_21_S012_R97515.CEL.gz 4.8 Mb (ftp)(http) CEL
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap